🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Self-Myofascial Release Plus Exercise Versus Exercise Alone in Type 2 Diabetes

RecruitingNAAges 30 Years - 65 YearsFemaleIzmir Katip Celebi University
NCT07414914 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized controlled trial aims to investigate the effects of adding self-myofascial release applied to the plantar fascia and gastrosoleus muscles to an exercise program on foot function, physical performance, and plantar fascia thickness in individuals with type 2 diabetes. Participants aged 30 to 65 years with controlled type 2 diabetes will be randomly allocated to either an exercise-only group or an exercise plus self-myofascial release group. Both groups will complete an eight-week supervised exercise program three times per week. The intervention group will additionally perform self-myofascial release using a foam roller before exercise sessions. Outcomes will include foot function, balance, functional mobility, gait performance, and plantar fascia thickness assessed by ultrasonography before and after the intervention.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Individuals aged 30 to 65 years * Diagnosed with type 2 diabetes mellitus for at least 1 year * Controlled type 2 diabetes mellitus * Able to ambulate independently without assistive devices Exclusion Criteria: * Severe pes planus or pes cavus defined by the Foot Posture Index-6 (FPI-6) (score ≥ +10 or ≤ -5) * History of plantar fasciitis * Plantar fascia ulceration * Peripheral neuropathy * Diagnosed peripheral vascular disease * History of lower extremity surgery or fracture during last year * Rheumatologic or connective tissue disorders affecting soft tissue properties * Neurological or diagnosed cognitive disorders * Pregnancy * Other types of diabetes mellitus * Obesity (BMI \> 30 kg/m²) * Serious cardiopulmonary disorders, including heart failure, history of myocardial infarction, or severe chronic obstructive pulmonary disease or asthma
💊

What it tests

  • Exercise Program
  • Self-Myofascial Release
📍

Where

1 site
Bakırçay University Çiğli Regional Education Hospital
Izmir, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy